MODASAFE 200

What is MODASAFE 200?

MODASAFE 200 is a medicinal product belonging to the pharmacological group of analeptic and nootropic agents, developed to correct conditions associated with excessive daytime sleepiness and decreased cognitive performance. The manufacturer of the drug is the pharmaceutical company Orange City, which specializes in the production of certified medications to support the functions of the central nervous system. The dosage form of MODASAFE 200 is represented by tablets for oral administration, each of which contains a precisely dosed amount of the active substance, ensuring a predictable therapeutic effect. The drug is positioned as a means to increase mental performance, improve concentration, and combat pathological fatigue that does not disappear after a full rest. Thanks to its balanced composition, MODASAFE 200 allows maintaining a high level of activity throughout the day without the pronounced excitation characteristic of classic psychostimulants.

The pharmacological action of MODASAFE 200 is based on the ability of its active components to influence the neurotransmitter systems of the brain, in particular the metabolism of dopamine, norepinephrine, and histamine. Such a mechanism provides mild stimulation of cognitive functions without a significant load on the cardiovascular system, which favorably distinguishes the drug from traditional amphetamine-series stimulants. MODASAFE 200 is often considered a representative of the group of so-called "smart drugs," or nootropic stimulants, which are used for the temporary improvement of mental activity in healthy individuals. At the same time, the drug has clear medical indications determined by a physician after a thorough examination of the patient and the exclusion of other causes of chronic fatigue. The manufacturer Orange City ensures strict quality control at all stages of production, guaranteeing that each tablet complies with international standards of pharmaceutical safety.

In clinical practice, MODASAFE 200 has proven to be an effective remedy for patients suffering from narcolepsy, obstructive sleep apnea, and other disorders accompanied by severe daytime sleepiness. The drug helps restore a normal wakefulness and sleep rhythm, improves the quality of life of patients, and allows them to return to active professional activities. It is important to understand that MODASAFE 200 is not a self-medication tool, and its use requires prior consultation with a qualified doctor. Only a specialist can evaluate the appropriateness of prescribing the drug, take into account possible contraindications, and select the optimal dosage regimen considering the individual characteristics of the patient's body.

What is MODASAFE 200 prescribed for?

The main indication for prescribing MODASAFE 200 is narcolepsy — a chronic neurological disease characterized by uncontrollable daytime sleep attacks and sudden loss of muscle tone. The drug helps stabilize the wakefulness cycle, reduces the frequency of sudden falling asleep episodes, and allows patients to lead a more predictable lifestyle. The efficacy of MODASAFE 200 in narcolepsy is confirmed by numerous clinical studies demonstrating a significant improvement in daytime activity after the first weeks of therapy. Doctors also note a positive effect of the drug on the emotional state of patients, as the reduction of sleepiness helps decrease anxiety and social isolation.

The second important indication is obstructive sleep apnea syndrome, in which patients suffer from repeated breathing pauses during sleep, leading to chronic sleep deprivation and pronounced daytime sleepiness. MODASAFE 200 is used as an adjunctive agent in the complex therapy of this condition when the main treatment using CPAP machines does not fully eliminate fatigue symptoms. The drug allows patients to stay alert during the workday, improves reaction speed, and reduces the risk of accidents associated with falling asleep at the wheel or while performing dangerous activities. It is important to emphasize that MODASAFE 200 does not treat apnea itself, but only corrects its consequences, so the main therapy should continue in full.

In some cases, MODASAFE 200 is prescribed for shift work sleep disorder, when disruption of circadian rhythms leads to chronic fatigue and reduced work capacity. The drug helps adapt to night shifts, frequent flights, and other situations requiring a temporary shift in sleep and wakefulness periods. MODASAFE 200 may also be recommended for severe asthenia accompanying certain somatic diseases when the patient experiences constant weakness and inability to concentrate. The decision to prescribe the drug in each specific case is made by a doctor, taking into account the balance of expected benefits and potential risks to the patient's health.

Composition and active components of MODASAFE 200

The active ingredient of MODASAFE 200 is modafinil at a dosage of 200 milligrams per tablet. Modafinil belongs to the class of atypical central nervous system stimulants that selectively act on specific brain regions responsible for regulating the sleep-wake cycle. Unlike classic psychostimulants, modafinil does not cause pronounced euphoria, tremors, or excessive agitation, which makes its use more comfortable for the patient. The mechanism of action of the substance lies in the inhibition of dopamine reuptake, which leads to an increase in its concentration in the synaptic cleft and activation of dopaminergic pathways responsible for maintaining wakefulness.

Additionally, modafinil affects the brain's histamine system by stimulating the release of histamine in the hypothalamus, which enhances the feeling of wakefulness and improves cognitive function. A moderate effect on the norepinephrine and serotonin systems is also noted, providing a comprehensive effect of increasing attention, improving memory, and learning capacity. Excipients of MODASAFE 200 include lactose, microcrystalline cellulose, starch, magnesium stearate, and other substances that ensure the stability of the tablet, its proper solubility, and bioavailability of the active substance. The manufacturer Orange City uses high-quality raw materials that undergo multi-stage testing for compliance with pharmacopoeial requirements.

The pharmacokinetics of MODASAFE 200 is characterized by rapid absorption after oral administration, reaching peak plasma concentrations in two to three hours, and a long elimination half-life of about twelve to fifteen hours. Such a profile allows taking the drug once daily, providing a stable therapeutic effect throughout the day. Modafinil metabolism occurs mainly in the liver with the participation of cytochrome P450 system enzymes, which should be considered when co-administering other medicinal products. Excretion of metabolites is carried out by the kidneys; therefore, patients with impaired renal function may require dose adjustment.

Dosage of MODASAFE 200

The standard recommended dose of MODASAFE 200 for adult patients is 200 milligrams once daily, usually in the morning or one hour before starting a work shift. This dosage regimen provides an optimal therapeutic effect throughout the active period without disturbing night sleep. For patients with narcolepsy, taking the drug in the morning after waking up is recommended, avoiding episodes of sudden falling asleep in the first half of the day. In cases of shift work schedules, the administration time may be adjusted by a doctor according to the patient's individual sleep and wakefulness schedule.

In certain clinical situations, a doctor may prescribe an initial dose of 100 milligrams to evaluate individual tolerability of the drug, followed by an increase to the standard dose of 200 milligrams in the absence of side effects. The maximum daily dose of MODASAFE 200 usually does not exceed 400 milligrams; however, such a dosage is used only in exceptional cases under strict medical supervision. Elderly patients may require a dose reduction due to age-related slowing of metabolism and increased sensitivity to the action of active substances. The duration of treatment is determined individually depending on the diagnosis, severity of symptoms, and the patient's response to therapy.

It is important to adhere to the prescribed dosage regimen and not exceed the recommended daily dose, as this may lead to adverse reactions from the nervous and cardiovascular systems. If a regular dose of MODASAFE 200 is missed, a double dose should not be taken to compensate, as this increases the risk of overdose. If less than six hours remain before the next intake, skipping the missed dose and returning to the regular schedule is recommended. Dose adjustment may be required for patients with impaired liver function, as this organ is responsible for metabolizing the active substance of the drug.

How to take MODASAFE 200 correctly?

MODASAFE 200 is taken orally; the tablet should be swallowed whole with a sufficient amount of water, without chewing or crushing. The drug can be taken regardless of food intake, although taking it with food may slightly delay the rate of absorption of the active substance, which does not significantly affect the overall efficacy of therapy. To achieve the maximum therapeutic effect, taking MODASAFE 200 at the same time every day is recommended, contributing to the formation of a stable concentration of the drug in the body. For patients working night shifts, a doctor may advise taking the tablet one hour before starting work to ensure an optimal level of alertness during the most critical period.

During MODASAFE 200 therapy, it is important to maintain an adequate sleep schedule, as the drug does not replace the body's physiological need for rest. Chronic sleep deprivation while taking stimulants can lead to exhaustion of the nervous system and a paradoxical decline in cognitive functions. Patients are advised to sleep at least seven to eight hours per day, avoid consuming caffeine-containing beverages in the second half of the day, and follow a regular sleep schedule. If difficulty falling asleep occurs after taking MODASAFE 200, a doctor should be informed, who may adjust the time of administration or the dose of the drug.

Special attention should be paid to maintaining adequate fluid intake, as modafinil can cause mild dehydration. Consuming a sufficient amount of fluid throughout the day is recommended, especially in hot weather or during intense physical exertion. Women of childbearing potential taking MODASAFE 200 should use reliable methods of contraception, as the drug may reduce the efficacy of hormonal contraceptives. Before starting therapy, a full medical examination must be completed, including an electrocardiogram and assessment of liver function, to rule out hidden contraindications.

Side effects of MODASAFE 200

The most common side effects of MODASAFE 200 are headaches, which occur in approximately ten percent of patients, as well as nervousness, anxiety, and sleep disturbances. These symptoms are usually mild to moderate and resolve spontaneously during the first days of therapy as the body adapts to the drug. Some patients experience decreased appetite, dry mouth, nausea, or dyspeptic symptoms, which can be minimized by taking the tablet after meals. It is important to distinguish temporary adaptation reactions from persistent side effects that require medical consultation and potential adjustment of the drug dosage.

Less common adverse reactions of MODASAFE 200 include tachycardia, increased blood pressure, palpitations, and chest discomfort. Patients with cardiovascular diseases should monitor their condition particularly closely during therapy and regularly check blood pressure readings. Rare but serious side effects include allergic reactions, including skin rash, urticaria, angioedema, and in isolated cases, severe cutaneous reactions such as Stevens-Johnson syndrome. If any signs of an allergy appear, the drug must be discontinued immediately, and medical help sought.

Psychiatric side effects of MODASAFE 200 may include increased irritability, emotional lability, impaired concentration, and in rare cases, hallucinations or manic states. Patients with pre-existing psychiatric disorders require special monitoring during treatment, as the drug may exacerbate symptoms of the underlying disease. The individual response of the body to MODASAFE 200 can vary significantly, so if any unusual symptoms occur, consulting a doctor to assess the benefit-risk ratio of continuing therapy is necessary. In most cases, side effects are temporary and completely disappear after stopping the drug.

Contraindications of MODASAFE 200

Absolute contraindications to the use of MODASAFE 200 are hypersensitivity to modafinil or any auxiliary component of the drug, as well as a history of severe allergic reactions to medications. The drug is not prescribed to patients with severe arterial hypertension, uncontrolled heart rhythm disorders, ischemic heart disease, and other serious cardiovascular diseases, as the stimulating effect can trigger exacerbation of these conditions. MODASAFE 200 is contraindicated in severe hepatic and renal impairment, when the body's ability to metabolize and excrete the drug is significantly reduced. Patients with psychotic disorders, bipolar affective disorder, and suicidal ideation are not prescribed the drug due to the risk of exacerbating psychiatric symptoms.

Relative contraindications requiring special caution are pregnancy and lactation, as there are insufficient data on the safety of modafinil use in these patient groups. Animal studies have shown a potential risk to the fetus; therefore, the drug is prescribed to pregnant women only in cases where the expected benefit to the mother outweighs the possible risk to the child. MODASAFE 200 is not used in pediatric practice for the treatment of children under eighteen years of age due to the lack of sufficient clinical data on efficacy and safety in this age group. Elderly patients require careful dose selection and regular monitoring of liver, kidney, and cardiovascular functions throughout the treatment period.

Patients with a history of substance abuse or dependence require special attention, as modafinil has a certain abuse potential, although significantly lower compared to classic stimulants. The physician must evaluate the risk of developing dependence in each individual case and ensure proper control over the use of the drug. For patients with epilepsy, MODASAFE 200 is prescribed with caution, as the stimulating action may lower the seizure threshold. Before starting therapy, it is necessary to inform the doctor about all existing diseases and medications taken to avoid dangerous interactions and complications.

Interaction of MODASAFE 200 with other drugs and alcohol

MODASAFE 200 can interact with many medicinal products due to its effect on the liver enzyme system, particularly cytochrome P450. The drug reduces the effectiveness of hormonal contraceptives; therefore, women taking birth control pills are recommended to use additional barrier methods of protection throughout the treatment period and for one month after its completion. Concomitant use of MODASAFE 200 with antidepressants, specifically monoamine oxidase inhibitors and selective serotonin reuptake inhibitors, requires caution due to the risk of developing serotonin syndrome. Patients taking anticoagulants, antiepileptic drugs, or medications for hypertension should inform their doctor before starting MODASAFE 200 therapy for possible dose adjustments.

Alcohol consumption during treatment with MODASAFE 200 is not recommended, as ethanol can enhance the side effects of the drug on the central nervous system and increase the risk of toxic liver damage. Alcohol can also mask the effect of the drug, creating a false impression of insufficient efficacy and prompting the patient to dangerously increase the dose. Regarding driving vehicles, MODASAFE 200 usually improves reaction speed and attention; however, dizziness and visual disturbances are possible at the beginning of therapy, so one should refrain from driving until the condition stabilizes. Patients whose professional activities involve increased concentration are advised to assess their individual response to the drug before performing responsible tasks.

Where to buy MODASAFE 200 in Ukraine

MODASAFE 200 is available for purchase in pharmacy chains across Ukraine upon presentation of a prescription issued by a doctor according to established requirements. The drug can also be ordered through certified online platforms specializing in the sale of medicinal products; however, it is important to ensure the reliability of the supplier and the availability of appropriate licenses. The manufacturer Orange City provides proper conditions for transportation and storage of products, guaranteeing the preservation of therapeutic properties of the drug throughout its shelf life. MODASAFE 200 should be stored in a dry place protected from light at a temperature not exceeding twenty-five degrees Celsius, out of the reach of children.

Before purchasing MODASAFE 200, it is mandatory to consult a doctor who will confirm the appropriateness of using the drug and issue a corresponding prescription. Self-medication with central nervous system stimulants can lead to serious health consequences, including the development of dependence, heart rhythm disorders, and psychiatric disorders. The individual response of the body to MODASAFE 200 can vary significantly; therefore, only a qualified specialist can determine the optimal dosage regimen and duration of treatment. Patients are advised to carefully read the instructions for the drug before starting therapy and contact a doctor if any questions or unusual symptoms arise.